Literature DB >> 7834862

Cystic fibrosis and phosphatidylcholine biosynthesis.

M M Ulane1, J D Butler, A Peri, L Miele, R E Ulane, V S Hubbard.   

Abstract

The cystic fibrosis (CF) gene defect may be associated with a defect in membrane recycling. We have investigated the metabolism of the main constituent of plasma membrane, phosphatidylcholine (PC). In this study of platelets and fibroblasts, we show an increased uptake of choline into PC of CF cells as compared with normal cells. No accumulation of PC was seen. Other patients with respiratory disease (not CF) showed normal rates of incorporation of choline into platelet PC. Platelets from heterozygote individuals showed intermediate turnover rates of choline incorporation into PC. The increase in choline incorporation into PC in CF platelets was not due to modified or increased sensitivity to either cAMP or prostaglandin E2. The total amount and the proportions of the major phospholipids in platelets of control and CF individuals were identical. These findings indicate an increased turnover rate of this phospholipid in CF cells rather than an increased net synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834862     DOI: 10.1016/0009-8981(94)90263-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial.

Authors:  Virginia A Stallings; Joan I Schall; Asim Maqbool; Maria R Mascarenhas; Belal N Alshaikh; Kelly A Dougherty; Kevin Hommel; Jamie Ryan; Okan U Elci; Walter A Shaw
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

2.  Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial.

Authors:  Joan I Schall; Maria R Mascarenhas; Asim Maqbool; Kelly A Dougherty; Okan Elci; Dah-Jyuu Wang; Talissa A Altes; Kevin A Hommel; Walter Shaw; Jeff Moore; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-04       Impact factor: 2.839

3.  Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.

Authors:  W Bernhard; J Y Wang; T Tschernig; B Tümmler; H J Hedrich; H von der Hardt
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

4.  Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism.

Authors:  Charlotte Andersson; M Rabie Al-Turkmani; Juanito E Savaille; Ragheed Alturkmani; Waddah Katrangi; Joanne E Cluette-Brown; Munir M Zaman; Michael Laposata; Steven D Freedman
Journal:  J Lipid Res       Date:  2008-04-25       Impact factor: 5.922

Review 5.  Nutrition in Cystic Fibrosis-Some Notes on the Fat Recommendations.

Authors:  Birgitta Strandvik
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

6.  Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial.

Authors:  Cinzia Scambi; Lucia De Franceschi; Patrizia Guarini; Fabio Poli; Angela Siciliano; Patrizia Pattini; Andrea Biondani; Valentina La Verde; Oscar Bortolami; Francesco Turrini; Franco Carta; Ciro D'Orazio; Baroukh M Assael; Giovanni Faccini; Lisa M Bambara
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

7.  A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

Authors:  Ida Chiara Guerrera; Giuseppe Astarita; Jean-Philippe Jais; Dorota Sands; Anna Nowakowska; Julien Colas; Isabelle Sermet-Gaudelus; Martin Schuerenberg; Daniele Piomelli; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

8.  Transient in utero disruption of cystic fibrosis transmembrane conductance regulator causes phenotypic changes in alveolar type II cells in adult rats.

Authors:  Ashraf Gad; Delon L Callender; Erin Killeen; Joseph Hudak; Malgosia A Dlugosz; Janet E Larson; J Craig Cohen; Avinash Chander
Journal:  BMC Cell Biol       Date:  2009-03-31       Impact factor: 4.241

9.  Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta.

Authors:  Nara Liessi; Emanuela Pesce; Clarissa Braccia; Sine Mandrup Bertozzi; Alessandro Giraudo; Tiziano Bandiera; Nicoletta Pedemonte; Andrea Armirotti
Journal:  JCI Insight       Date:  2020-08-20

Review 10.  Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?

Authors:  Birgitta Strandvik
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.